Longeveron Inc (LGVN)

Dec 11, 2025

Longeveron launches offering of up to 11.8M shares via warrants and stock units - MSN

Dec 11, 2025

Dec 09, 2025

Prepare Yourself for Liftoff: Longeveron Inc (LGVN) - Setenews

Dec 09, 2025

Dec 04, 2025

Update Recap: Can MCK stock sustain institutional flowsWatch List & Free Weekly Watchlist of Top Performers - BỘ NỘI VỤ

Dec 04, 2025

Dec 03, 2025

Longeveron granted Canadian patent covering laromestrocel administration - MSN

Dec 03, 2025

Dec 03, 2025

Longeveron executives to speak at CVCT Forum on cell therapy trials - Investing.com Nigeria

Dec 03, 2025

Dec 03, 2025

Longeveron Chief Science Officer and Chief Medical Officer Selected as Speakers at the Global CardioVascular Clinical Trialists (CVCT) Forum - The Manila Times

Dec 03, 2025

Dec 03, 2025

Longeveron (NASDAQ: LGVN) CSO, CMO to Join CVCT Forum Panels on Cell Therapy Trials - Stock Titan

Dec 03, 2025

Dec 03, 2025

Can Longeveron Inc. stock continue upward trendWeekly Trend Recap & Fast Entry Momentum Alerts - Newser

Dec 03, 2025

Dec 03, 2025

Longeveron (LGVN) Stock Analysis Report | Ratings, Financials & Performance - Benzinga

Dec 03, 2025

Dec 02, 2025

Longeveron receives Canadian patent for stem cell therapy By Investing.com - Investing.com Nigeria

Dec 02, 2025

Dec 02, 2025

Perhaps timely catching Longeveron Inc (LGVN) would be a good idea - Setenews

Dec 02, 2025

Dec 02, 2025

Longeveron receives Canadian patent for stem cell therapy - Investing.com

Dec 02, 2025

Dec 02, 2025

Longeveron granted Canadian patent for method of using stem cells to treat non-ischemic dilated cardiomyopathy - MarketScreener

Dec 02, 2025

Dec 02, 2025

Longeveron Granted Canadian Patent for Method of Using Stem Cells to Treat Non-Ischemic Dilated Cardiomyopathy and Aging-related Frailty in Patients with Inflammaging - The Manila Times

Dec 02, 2025

Dec 02, 2025

Longeveron (NASDAQ: LGVN) gets Canada patent on LOMECEL-B for frailty and NIDCM - Stock Titan

Dec 02, 2025

Dec 02, 2025

Longeveron New MRI Biomarker Data Linking Neuroinflammation to Clinical Outcomes in Patients with Mild Alzheimer’s Disease Presented at the Clinical Trials on Alzheimer’s Disease Conference (CTAD 2025) - The Manila Times

Dec 02, 2025

Dec 01, 2025

Longeveron’s stem cell therapy shows reduced neuroinflammation in AD trial By Investing.com - Investing.com South Africa

Dec 01, 2025

Dec 01, 2025

Longeveron to present MRI biomarker data in Alzheimer’s at CTAD 2025 - TipRanks

Dec 01, 2025

Dec 01, 2025

Longeveron (NASDAQ: LGVN) sees MRI inflammation drop in 13 of 14 brain regions at week 39 - Stock Titan

Dec 01, 2025

Nov 29, 2025

Longeveron (NASDAQ:LGVN) Shares Up 3% – Should You Buy? - Defense World

Nov 29, 2025

Nov 28, 2025

Longeveron announces board member resignation - MSN

Nov 28, 2025

Nov 28, 2025

Is Longeveron Inc. stock a buy in volatile marketsJuly 2025 Price Swings & Safe Swing Trade Setups - moha.gov.vn

Nov 28, 2025

Nov 28, 2025

Longeveron Inc. (LGVN) Jumps 6% in Pre-market: What’s Driving the Move? - Stocks Telegraph

Nov 28, 2025

Nov 27, 2025

Will Longeveron Inc. stock attract more institutional investorsJuly 2025 Selloffs & Entry Point Confirmation Signals - BỘ NỘI VỤ

Nov 27, 2025

Nov 26, 2025

Longeveron Inc. (LGVN) 5.03% in After-hours: What’s Driving the Move? - Stocks Telegraph

Nov 26, 2025

Nov 20, 2025

Take off with Longeveron Inc (LGVN): Get ready for trading - Setenews

Nov 20, 2025

Nov 19, 2025

What data driven models say about Longeveron Inc.’s futureJuly 2025 Sector Moves & Reliable Breakout Forecasts - newser.com

Nov 19, 2025

Nov 19, 2025

Longeveron Inc. (LGVN) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Nov 19, 2025

Nov 19, 2025

Longeveron to present Alzheimer's treatment data at CTAD 2025 By Investing.com - Investing.com Nigeria

Nov 19, 2025

Nov 19, 2025

Longeveron to present Alzheimer’s treatment data at CTAD 2025 By Investing.com - Investing.com Australia

Nov 19, 2025

Nov 19, 2025

Will Longeveron Inc. stock remain a Wall Street favorite2025 Dividend Review & Community Shared Stock Ideas - newser.com

Nov 19, 2025

Nov 19, 2025

Longeveron to present Alzheimer’s treatment data at CTAD 2025 - Investing.com

Nov 19, 2025

Nov 19, 2025

Longeveron Laromestrocel Data in Alzheimer’s Disease Selected for Poster Presentation at the Clinical Trials on Alzheimer’s Disease Conference (CTAD 2025) - The Manila Times

Nov 19, 2025

Nov 19, 2025

Longeveron (NASDAQ: LGVN) Presenting Laromestrocel CLEAR MIND Data at CTAD 2025 - Stock Titan

Nov 19, 2025

Nov 19, 2025

Why analysts upgrade Longeveron Inc. stock2025 Biggest Moves & Real-Time Sentiment Analysis - newser.com

Nov 19, 2025

Nov 16, 2025

Visualizing Longeveron Inc. stock with heatmapsJuly 2025 Momentum & Short-Term Swing Trade Alerts - newser.com

Nov 16, 2025

Nov 16, 2025

What drives Longeveron Inc stock priceHigh Beta Stocks & Budget Friendly Investment Plans - earlytimes.in

Nov 16, 2025

Nov 16, 2025

What dividend safety score for Longeveron Inc. stockWeekly Risk Report & Entry Point Confirmation Signals - newser.com

Nov 16, 2025

Nov 14, 2025

How Longeveron Inc. stock compares to growth peersJuly 2025 Big Picture & Expert Verified Movement Alerts - Fundação Cultural do Pará

Nov 14, 2025

Nov 14, 2025

Is Longeveron Inc. stock recession proof2025 Volume Leaders & High Accuracy Investment Signals - Fundação Cultural do Pará

Nov 14, 2025

Nov 13, 2025

Longeveron Faces Nasdaq Delisting Notice for Stock Price - MSN

Nov 13, 2025

Nov 13, 2025

Will Longeveron Inc. stock continue dividend increasesPortfolio Growth Summary & Weekly High Return Stock Forecasts - newser.com

Nov 13, 2025

Nov 12, 2025

Longeveron secures patent for stem cell therapy targeting aging frailty By Investing.com - Investing.com Nigeria

Nov 12, 2025

Nov 12, 2025

Longeveron announces resignations of two board members By Investing.com - Investing.com Australia

Nov 12, 2025